Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Walter A Scott

Showing results (11-20 of 14) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 14 results.
Antimicrobial Agents and Chemotherapy|August 5, 2020
Nucleocapsid Protein Precursors NCp9 and NCp15 Suppress ATP-Mediated Rescue of AZT-Terminated Primers by HIV-1 Reverse TranscriptaseMoisés A Árquez, Samara Martín-Alonso, Robert J Gorelick, et al.
Antimicrobial Agents and Chemotherapy|April 18, 2002
Effects of specific zidovudine resistance mutations and substrate structure on nucleotide-dependent primer unblocking by human immunodeficiency virus type 1 reverse transcriptasePeter R Meyer, Suzanne E Matsuura, Adviye A Tolun, et al.
Journal of Virology|May 14, 2003
Relationship between 3'-azido-3'-deoxythymidine resistance and primer unblocking activity in foscarnet-resistant mutants of human immunodeficiency virus type 1 reverse transcriptasePeter R Meyer, Suzanne E Matsuura, Dianna Zonarich, et al.
Virology|November 6, 2004
Influence of CD4+ T cell counts on viral evolution in HIV-infected individuals undergoing suppressive HAARTEric Lorenzo, Maria C Colon, Sharilyn Almodovar, et al.
Pageof 2

Showing results (11-20 of 14) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 14 results.
Antimicrobial Agents and Chemotherapy|August 5, 2020
Nucleocapsid Protein Precursors NCp9 and NCp15 Suppress ATP-Mediated Rescue of AZT-Terminated Primers by HIV-1 Reverse TranscriptaseMoisés A Árquez, Samara Martín-Alonso, Robert J Gorelick, et al.
Antimicrobial Agents and Chemotherapy|April 18, 2002
Effects of specific zidovudine resistance mutations and substrate structure on nucleotide-dependent primer unblocking by human immunodeficiency virus type 1 reverse transcriptasePeter R Meyer, Suzanne E Matsuura, Adviye A Tolun, et al.
Journal of Virology|May 14, 2003
Relationship between 3'-azido-3'-deoxythymidine resistance and primer unblocking activity in foscarnet-resistant mutants of human immunodeficiency virus type 1 reverse transcriptasePeter R Meyer, Suzanne E Matsuura, Dianna Zonarich, et al.
Virology|November 6, 2004
Influence of CD4+ T cell counts on viral evolution in HIV-infected individuals undergoing suppressive HAARTEric Lorenzo, Maria C Colon, Sharilyn Almodovar, et al.
Pageof 2